Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 252

1.

Clinical implications of nonspecific pulmonary nodules identified during the initial evaluation of patients with head and neck squamous cell carcinoma.

Kwon M, Lee SH, Lee YS, Lee CW, Roh JL, Choi SH, Nam SY, Kim SY.

Eur Radiol. 2017 Feb 6. doi: 10.1007/s00330-017-4750-y. [Epub ahead of print]

PMID:
28168367
2.

Expression of Lysyl Oxidase Predictive of Distant Metastasis of Laryngeal Cancer.

Lee YS, Park Y, Kwon M, Roh JL, Choi SH, Nam SY, Kim SY.

Otolaryngol Head Neck Surg. 2017 Mar;156(3):489-497. doi: 10.1177/0194599816685698. Epub 2017 Jan 24.

PMID:
28116994
3.

Postdiagnostic use of β-blockers and other antihypertensive drugs and the risk of recurrence and mortality in head and neck cancer patients: an observational study of 10,414 person-years of follow-up.

Kim SA, Moon H, Roh JL, Kim SB, Choi SH, Nam SY, Kim SY.

Clin Transl Oncol. 2017 Jan 16. doi: 10.1007/s12094-016-1608-8. [Epub ahead of print]

PMID:
28093700
4.

18F-FDG PET/CT Versus Contrast-Enhanced CT for Staging and Prognostic Prediction in Patients With Salivary Gland Carcinomas.

Park MJ, Oh JS, Roh JL, Kim JS, Lee JH, Nam SY, Kim SY.

Clin Nucl Med. 2017 Mar;42(3):e149-e156. doi: 10.1097/RLU.0000000000001515.

PMID:
28072618
5.

Aspirin plus sorafenib potentiates cisplatin cytotoxicity in resistant head and neck cancer cells through xCT inhibition.

Roh JL, Kim EH, Jang H, Shin D.

Free Radic Biol Med. 2017 Mar;104:1-9. doi: 10.1016/j.freeradbiomed.2017.01.002. Epub 2017 Jan 3.

PMID:
28057599
6.

Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery.

Korean Society of Thyroid-Head and Neck Surgery Guideline Task Force., Ahn SH, Hong HJ, Kwon SY, Kwon KH, Roh JL, Ryu J, Park JH, Baek SK, Lee GH, Lee SY, Lee JC, Chung MK, Joo YH, Ji YB, Hah JH, Kwon M, Park YM, Song CM, Shin SC, Ryu CH, Lee DY, Lee YC, Chang JW, Jeong HM, Cho JK, Cha W, Chun BJ, Choi IJ, Choi HG, Lee KD.

Clin Exp Otorhinolaryngol. 2017 Mar;10(1):1-43. doi: 10.21053/ceo.2016.01389. Epub 2017 Jan 3.

7.

18F-FDG PET/CT surveillance for the detection of recurrence in patients with head and neck cancer.

Kim SA, Roh JL, Kim JS, Lee JH, Lee SH, Choi SH, Nam SY, Kim SY.

Eur J Cancer. 2017 Feb;72:62-70. doi: 10.1016/j.ejca.2016.11.009. Epub 2016 Dec 24.

PMID:
28027517
8.

Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.

Roh JL, Kim EH, Jang H, Shin D.

Redox Biol. 2017 Apr;11:254-262. doi: 10.1016/j.redox.2016.12.010. Epub 2016 Dec 18.

9.

Prevalence and clinical significance of cancer cachexia based on time from treatment in advanced-stage head and neck squamous cell carcinoma.

Kwon M, Kim RB, Roh JL, Lee SW, Kim SB, Choi SH, Nam SY, Kim SY.

Head Neck. 2017 Apr;39(4):716-723. doi: 10.1002/hed.24672. Epub 2016 Dec 21.

PMID:
28000343
10.

Incidence and risk factors of late recurrence in patients with salivary gland cancer.

Park GC, Roh JL, Cho KJ, Jin MH, Choi SH, Nam SY, Kim SY.

Clin Otolaryngol. 2017 Apr;42(2):416-424. doi: 10.1111/coa.12808. Epub 2017 Jan 8.

PMID:
27960047
11.

18 F-FDG PET/CT vs. human papillomavirus, p16 and Epstein-Barr virus detection in cervical metastatic lymph nodes for identifying primary tumors.

Cheol Park G, Roh JL, Cho KJ, Seung Kim J, Hyeon Jin M, Choi SH, Yuhl Nam S, Yoon Kim S.

Int J Cancer. 2017 Mar 15;140(6):1405-1412. doi: 10.1002/ijc.30550.

PMID:
27943271
12.

Increased Immunoglobulin G4-positive Plasma Cells in Lymphadenoma of the Salivary Gland: An Immunohistochemical Comparison Among Lymphoepithelial Lesions.

Kim J, Song JS, Roh JL, Choi SH, Nam SY, Kim SY, Cho KJ.

Appl Immunohistochem Mol Morphol. 2016 Dec 9. [Epub ahead of print]

PMID:
27941558
13.

The influence of pediatric tracheostomy on the body weight percentile of children.

Yankasari S, Lee YS, Chang WK, Moon H, Kim J, Roh JL, Choi SH, Kim SY, Nam SY.

Int J Pediatr Otorhinolaryngol. 2016 Dec;91:49-54. doi: 10.1016/j.ijporl.2016.10.011. Epub 2016 Oct 14.

PMID:
27863641
14.

A Novel Polyphenol Conjugate Sensitizes Cisplatin-Resistant Head and Neck Cancer Cells to Cisplatin via Nrf2 Inhibition.

Kim EH, Jang H, Roh JL.

Mol Cancer Ther. 2016 Nov;15(11):2620-2629. Epub 2016 Aug 22.

PMID:
27550943
15.

Risk Factors and Survival Associated with Distant Metastasis in Patients with Carcinoma of the Salivary Gland.

Nam SJ, Roh JL, Cho KJ, Choi SH, Nam SY, Kim SY.

Ann Surg Oncol. 2016 Dec;23(13):4376-4383. Epub 2016 Jun 23.

PMID:
27338749
16.

Reply to a Letter to the Editor: can we really consider tumor size and surgical extent as predictive factors for recurrence in clinically early-stage papillary thyroid carcinoma patients?

Roh JL, Kim JW.

Am J Surg. 2016 Nov;212(5):1031-1032. doi: 10.1016/j.amjsurg.2016.05.016. Epub 2016 Jul 21. No abstract available.

PMID:
27523924
17.
18.

Targeting of the Glutathione, Thioredoxin, and Nrf2 Antioxidant Systems in Head and Neck Cancer.

Roh JL, Jang H, Kim EH, Shin D.

Antioxid Redox Signal. 2016 Nov 14. doi: 10.1089/ars.2016.6841. [Epub ahead of print]

PMID:
27733046
19.

Extent of Extrathyroidal Extension as a Significant Predictor of Nodal Metastasis and Extranodal Extension in Patients with Papillary Thyroid Carcinoma.

Kim JW, Roh JL, Gong G, Cho KJ, Choi SH, Nam SY, Kim SY.

Ann Surg Oncol. 2017 Feb;24(2):460-468. doi: 10.1245/s10434-016-5594-4. Epub 2016 Sep 21.

PMID:
27654105
20.

Interobserver reproducibility of cervical lymph node measurements at CT in patients with head and neck squamous cell carcinoma.

Chung MS, Cheng KL, Choi YJ, Roh JL, Lee YS, Lee SS, Lee JH, Baek JH.

Clin Radiol. 2016 Dec;71(12):1226-1232. doi: 10.1016/j.crad.2016.07.014. Epub 2016 Aug 25.

PMID:
27569854

Supplemental Content

Support Center